SFI
CODX

Susquehanna Fundamental Investments’s Co-Diagnostics CODX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$131K Sell
707
-714
-50% -$148K ﹤0.01% 1429
2021
Q4 		$381K Sell
1,421
-2,104
-60% -$552K 0.01% 1029
2021
Q3 		$1.03M Buy
3,525
+1,330
+61% +$388K 0.02% 846
2021
Q2 		$543K Buy
+2,195
New +$564K 0.01% 1127

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Susquehanna Fundamental Investments's CODX Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Co-Diagnostics (CODX) stake by 50% in Q1 2022, selling an estimated $148K and leaving 707 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Susquehanna Fundamental Investments first reported a position in CODX in Q2 2021 and has held it in 4 quarters since. The position peaked at $1.03M in Q3 2021. 82 funds tracked by Wall St. Rank hold CODX as of Q1 2022.

  • Susquehanna Fundamental Investments held 707 shares of Co-Diagnostics worth $131K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 714 Co-Diagnostics shares in Q1 2022, an estimated $148K.
  • Co-Diagnostics made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1429 holding.
  • Susquehanna Fundamental Investments first reported a position in Co-Diagnostics in Q2 2021 and has held it in 4 quarters since.
  • Susquehanna Fundamental Investments's Co-Diagnostics position peaked at $1.03M in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.